Recent

% | $
Quotes you view appear here for quick access.

Osiris Therapeutics, Inc. Message Board

  • thirdbse6422002 thirdbse6422002 Aug 9, 2012 8:43 PM Flag

    I HATE TO THINK THE MARKET IS JUST CRUEL AND WANTS TO TAKE YOUR MONEY

    i really do

    seeking alpha hit this once it was ripe for the taking

    earnings-stem cells lol

    but earnings are a few months away

    we see the growth
    hard not to bet on this

    i see on the chart this being wayyy up their

    we will have more problems with seeking alpha in the 30.s

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The disturbance in the Force is due to Sanofi, the broken second leg of our three legged stool. Leg #1 is Prochymal, and while Health Canada and New Zealand have approved it, Sanofi clearly and defiantly stands in the way. The third leg is AMI, also tied to Sanofi by a $20 million phase 2 milestone never paid.

      Biosurgery is a GIVEN, more or less. The Grafix phase 4 has nothing to do with ongoing sales expansion. Ovation is for bone repair.

      QUESTION: Cartiform and Chondrogen appear to target the same indications. Are they slightly different?

      Anyway, if Sanofi goes away and Abbott comes on board with plans for a MSC cardiac stent. This would be ideal. I have already described why this is a real possiblity: 1. Abbott almost partnered with Mesoblast for heart stem cells. 2. Stem cell on an absorbable stent are the next big thing.

      Lets see how this plays out shall we?

 
OSIR
18.20-0.16(-0.87%)May 22 4:00 PMEDT